These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 36200211)

  • 1. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
    Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
    Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration.
    Mahbub NU; Islam MM; Hong ST; Chung HJ
    Front Cell Infect Microbiol; 2024; 14():1348279. PubMed ID: 38435303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome.
    Bicknell B; Liebert A; Borody T; Herkes G; McLachlan C; Kiat H
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gut dysbiosis in Parkinson's disease: mechanistic insights and therapeutic options.
    Wang Q; Luo Y; Ray Chaudhuri K; Reynolds R; Tan EK; Pettersson S
    Brain; 2021 Oct; 144(9):2571-2593. PubMed ID: 33856024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Gut Microbiota and Gut-Brain Interplay in Selected Diseases of the Central Nervous System.
    Doroszkiewicz J; Groblewska M; Mroczko B
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gut microbiota-brain axis in neurological disorder.
    Ullah H; Arbab S; Tian Y; Liu CQ; Chen Y; Qijie L; Khan MIU; Hassan IU; Li K
    Front Neurosci; 2023; 17():1225875. PubMed ID: 37600019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease.
    Kaur G; Behl T; Bungau S; Kumar A; Uddin MS; Mehta V; Zengin G; Mathew B; Shah MA; Arora S
    Curr Neuropharmacol; 2021; 19(2):233-247. PubMed ID: 32504503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders.
    Chen Y; Xu J; Chen Y
    Nutrients; 2021 Jun; 13(6):. PubMed ID: 34205336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota- Brain-Gut-Axis Relevance to Parkinson's Disease: Potential Therapeutic Effects of Probiotics.
    Raj K; Singh S; Chib S; Mallan S
    Curr Pharm Des; 2022; 28(37):3049-3067. PubMed ID: 36200207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Human Gut Microbiome as a Potential Factor in Autism Spectrum Disorder.
    Alharthi A; Alhazmi S; Alburae N; Bahieldin A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging insights between gut microbiome dysbiosis and Parkinson's disease: Pathogenic and clinical relevance.
    Bi M; Feng L; He J; Liu C; Wang Y; Jiang H; Liu SJ
    Ageing Res Rev; 2022 Dec; 82():101759. PubMed ID: 36243356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
    Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
    Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut-Brain Axis a Key Player to Control Gut Dysbiosis in Neurological Diseases.
    Pan I; Issac PK; Rahman MM; Guru A; Arockiaraj J
    Mol Neurobiol; 2024 Dec; 61(12):9873-9891. PubMed ID: 37851313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Microbiome-Brain Communication on Neuroinflammation and Neurodegeneration.
    Stolzer I; Scherer E; Süß P; Rothhammer V; Winner B; Neurath MF; Günther C
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pesticides and the Microbiome-Gut-Brain Axis: Convergent Pathways in the Pathogenesis of Parkinson's Disease.
    Kulcsarova K; Bang C; Berg D; Schaeffer E
    J Parkinsons Dis; 2023; 13(7):1079-1106. PubMed ID: 37927277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The connection between gut microbiota and its metabolites with neurodegenerative diseases in humans.
    Fabi JP
    Metab Brain Dis; 2024 Jun; 39(5):967-984. PubMed ID: 38848023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.